Although the transcriptomic signature of the tumor could not predict recurrence or the risk of progression, that of the TAN sample could successfully predict the recurrence of the disease and aid the stratification of patients into high-and low-risk groups.

This indicates the potential role of TAN tissue in future recurrence and its utility in predicting prognosis. However, TAN tissue could not accurately predict the formation of a new primary tumor.